NCT03131765View on ClinicalTrials.gov

Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

December 15, 2019

Study Completion Date

December 16, 2019

Conditions
Cancer
Interventions
BIOLOGICAL

YS-0N-001

Cancer vaccine

Trial Locations (1)

Unknown

National University Cancer Institute Singapore, Singapore

All Listed Sponsors
lead

Yisheng Biopharma (Singapore) Pte. Ltd.

INDUSTRY

NCT03131765 - Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter